| 缩写名/全名 |
EXPERT OPIN THER PAT
EXPERT OPINION ON THERAPEUTIC PATENTS |
||||||||||||||||||||
| ISSN号 | 1354-3776 | ||||||||||||||||||||
| 研究方向 | 医学-药学 | ||||||||||||||||||||
| 影响因子 | 2015:4.626, 2016:3.041, 2017:2.867, 2018:3.699, 2019:5.611, | ||||||||||||||||||||
| 出版国家 | ENGLAND | ||||||||||||||||||||
| 出版周期 | Monthly | ||||||||||||||||||||
| 年文章数 | 71 | ||||||||||||||||||||
| 出版年份 | 1994 | ||||||||||||||||||||
| 是否OA | No | ||||||||||||||||||||
| 审稿周期(仅供参考) | 较慢,6-12周 |
||||||||||||||||||||
| 录用比例 | 一般 | ||||||||||||||||||||
| 投稿链接 | https://mc.manuscriptcentral.com/eotp | ||||||||||||||||||||
| 投稿官网 | http://www.tandfonline.com/loi/ietp20#.V48csUz9cSQ | ||||||||||||||||||||
| h-index | 61 | ||||||||||||||||||||
| CiteScore |
|
||||||||||||||||||||
| PubMed Central (PMC)链接 | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1354-3776%5BISSN%5D | ||||||||||||||||||||
| 中科院SCI期刊分区 （ 2018年新版本） |
|
||||||||||||||||||||
| 中科院SCI期刊分区 （ 2020年新版本） |
|
| 中国学者近期发表的论文 | |
| 1. | Novel diarylpyrimidines and diaryltriazines as potent HIV-1 NNRTIs with dramatically improved solubility: a patent evaluation of US20140378443A1. Author: Huang B, Kang D, Yang J, Zhan P, Liu X. Journal: Expert Opin Ther Pat. 2016;26(2):281-9. doi: 10.1517/13543776.2016.1113256. Epub 2015 Nov 11. PubMed |
| 2. | RGD mimetics γ-AApeptides and methods of use (US 20,140,004,039 A1): a patent evaluation. Author: Wu H, Jiang J, Xu H, Li Q, Cai J. Journal: Expert Opin Ther Pat. 2016 Jan;26(1):131-7. doi: 10.1517/13543776.2016.1111337. Epub 2015 Nov 11. PubMed |
| 3. | Novel serotonin receptor 2 (5-HT2R) agonists and antagonists: a patent review (2004-2014). Author: Yang Y, An S, Liu Y, Guo XX, Gao L, Wei JF, Xu TR. Journal: Expert Opin Ther Pat. 2016 Jan;26(1):89-106. doi: 10.1517/13543776.2016.1113257. Epub 2015 Nov 26. PubMed |
| 4. | Analysis of anti-asthmatic drug patents published in China between 2004 and 2013. Author: Xie H, Zhang H, Cao K, He P, Dai H, He S. Journal: Expert Opin Ther Pat. 2016;26(3):363-76. doi: 10.1517/13543776.2016.1136289. Epub 2016 Jan 19. PubMed |
| 5. | Topical composition for treating diabetic cataracts: a patent evaluation (WO2015026380A1). Author: Hao X, Han Z, Zhu C. Journal: Expert Opin Ther Pat. 2016 Jun;26(6):731-5. doi: 10.1517/13543776.2016.1163339. Epub 2016 Mar 21. PubMed |
| 6. | Research and development of antibiotics: insights from patents and citation network. Author: Zhang M, Kong X, Zheng J, Wan JB, Wang Y, Hu Y, Shao R. Journal: Expert Opin Ther Pat. 2016 May;26(5):617-27. doi: 10.1517/13543776.2016.1167877. Epub 2016 Apr 6. PubMed |
| 7. | Novel compound, organic cation transporter 3 detection agent and organic cation transporter 3 activity inhibitor, WO2015002150 A1: a patent evaluation. Author: Hu T, Wang L, Pan X, Qi H. Journal: Expert Opin Ther Pat. 2016 Aug;26(8):857-60. doi: 10.1080/13543776.2016.1180364. Epub 2016 Apr 29. PubMed |
| 8. | Telomerase inhibitors: a patent review (2010-2015). Author: Man RJ, Chen LW, Zhu HL. Journal: Expert Opin Ther Pat. 2016 Jun;26(6):679-88. doi: 10.1080/13543776.2016.1181172. Epub 2016 May 12. PubMed |
| 9. | Fatty acid binding protein (FABP) inhibitors: a patent review (2012-2015). Author: Wang YT, Liu CH, Zhu HL. Journal: Expert Opin Ther Pat. 2016 Jul;26(7):767-76. doi: 10.1080/13543776.2016.1182500. Epub 2016 May 10. PubMed |
| 10. | Oleanolic acid derivatives for pharmaceutical use: a patent review. Author: Lin C, Wen X, Sun H. Journal: Expert Opin Ther Pat. 2016 Jun;26(6):643-55. doi: 10.1080/13543776.2016.1182988. Epub 2016 May 10. PubMed |
|
|
